6 result(s) displayed (1 - 6 of 6):

Heavyweight partnership for ice cream, doughnut chains (from Corporate Dealmaker)

Oh there is nothing quite like coffee and donuts ... and ice cream? That's right. Tim Hortons Inc., a coffee and doughnut shop, is partnering up with Kahala Corp.'s Cold Stone Creamery, the singing ice cream shop, to see if the combination of their brands in the same location can...

Posted on February 6, 2009 2:29 PM

United and Continental create alliance (from Corporate Dealmaker)

Less than two months after rejecting a marriage proposal from United Airlines Inc., Continental Airlines Inc. on Thursday decided it still wants to be friends. Houston-based Continental and United on Thursday announced plans for forming a comprehensive codesharing alliance, linking their networks and (hopefully) creating seamless connections for passengers of...

Posted on June 19, 2008 3:47 PM

Is the credit crunch turning acquirers into joint venturers? (from Corporate Dealmaker)

The folks at KPMG International think so. Using data compiled by Thomson Financial, KPMG predicts 2008 will be a boom year for creation of JVs, following three years of incremental growth. The reason, according to...

Posted on March 20, 2008 9:09 AM

New strategy chief for Qwest (from Corporate Dealmaker)

Former Qwest Communications International Inc. investor relations executive Stephanie Comfort has taken on dealmaking responsibilities as the Denver telecom's recently appointed executive vice president of corporate strategy. Comfort has been on the job since September 2007, though the announcement of her move had been delayed. Comfort moves into the position...

Posted on February 26, 2008 5:32 PM

Toward a more perfect partnership (from Corporate Dealmaker)

How can corporate development officers best work with line managers? Informal bridge building counts for a lot.

Posted on June 15, 2005 6:01 PM

Lilly's prescription for growth (from Corporate Dealmaker)

Eli Lilly and Co. spent $2.4 billion on life-science R&D last year, exploring everything from antisense technology to synthetic exendin-4. But the biggest experiment under way at the company isn't taking place in a lab or a clinic. And the results of that experiment - highly promising so far...

Posted on August 15, 2004 5:45 PM